Connect← Return to When to begin Salvage Radiation when BCR occurs?
Discussion
When to begin Salvage Radiation when BCR occurs?
Prostate Cancer | Last Active: Oct 10 10:34am | Replies (16)Comment receiving replies
I would kindly suggest that you do all of your research and be ready for BCR since there is always a lot of time needed to organize everything - from PSMA to MRI to getting approvals and deciding on a treatment and having appointments with RO and MO and having simulation done etc etc.
If we relied on DRs who went with their very relaxed pace, my husband who had fast doubling time would have started his RT much later than 0.2 which is a cut off PSA for achieving the best possible results.
So, you preferably need to have everything lined up and ready to START with RT at 0.2.
Replies to "@tom86 I would kindly suggest that you do all of your research and be ready for..."
@surftohealth88 I agree with Surf. Time to be a bit of a pain with your Dr's office. Narrow the window on the PSA timing, emphasize you want to go salvage early and tell them you understand radiation has risks but you personally want an agressive approach. There is a trend now to wait but make clear that is not the approach you prefer. That is just my feeling but having just been through this that is the approach I took. Do you have a sense for how fast it is rising? That may make a difference also. I did not have much time to act.
Connect
@surftohealth88
Yet again, I agree with Mrs Surf; her husband and I have very similar stories.
When my uPSA started creeping up post-RALP, I wanted to get on ADT right away, based on the information presented above by jeffmarc. Unfortunately, Orgyvx conflicted with my heart medication and it took a while to sort things out with my cardiologist. By the time I was put on bicalutamide (as a stopgap measure), I hit .215--not bad, but not great. Even though I think my RO is really good, I had to push things along to make things more quickly. So, getting as much as possible arranged in advance is a very good idea, especially for aggressive cancers that don't fit the "slow growth" model of most cancers.